HIV, Combination Antiretroviral Therapy, and Vascular Diseases in Men and Women - ScienceDirect
Adding a second step to CAR T-cell therapy may make it effective against HIV | Frederick National Laboratory
Nanomedicine applications towards the cure of HIV - ScienceDirect
Specific Activation In Vivo of HIV-1 by a Bromodomain Inhibitor from Monocytic Cells in Humanized Mice under Antiretroviral Therapy | Journal of Virology
Antiretroviral therapy in pregnant women living with HIV: a clinical practice guideline | The BMJ
Early initiation of combined antiretroviral therapy preserves immune function in the gut of HIV-infected patients | Mucosal Immunology
Frontiers | Insulin Resistance in HIV-Patients: Causes and Consequences
Replacing cART with CAR-T Cells: Using Immunotherapy to Cure HIV: Molecular Therapy
Molecular Mechanisms Controlling HIV Transcription and Latency – Implications for Therapeutic Viral Reactivation | IntechOpen
cART Restores Transient Responsiveness to IFN Type 1 in HIV-Infected Humanized Mice | Journal of Virology
JCI - TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs
Management of HIV/AIDS - Wikipedia
Figure 1 | Human Hematopoietic Stem Cell (HSC)-Engrafted NSG Mice for HIV Latency Research | SpringerLink
T-Cell Therapy for HIV: Genetic Engineering of Enhanced Function and HIV Resistance
Viruses | Free Full-Text | The Potential of Long-Acting, Tissue-Targeted Synthetic Nanotherapy for Delivery of Antiviral Therapy Against HIV Infection | HTML
HIV cure at CROI: new data on antibodies, vaccines and genetically engineered T-cells | aidsmap
Frontiers | The Potential Protective Role of Vitamin D Supplementation on HIV-1 Infection
Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury | SpringerLink
Association between HIV infection, cART, and disease progression on TNF... | Download Scientific Diagram
HIV-associated cardiovascular disease: importance of platelet activation and cardiac fibrosis in the setting of specific antiretroviral therapies | Open Heart
Persistent immune activation in chronic HIV infection: do any interventions work? (cure research)
Defective HIV-1 proviruses produce viral proteins | PNAS
JCI Insight - Type I interferons and TGF-β cooperate to induce liver fibrosis during HIV-1 infection under antiretroviral therapy
HIGH-FREQUENCY failure of combination antiretroviral therapy in paediatric HIV infection is associated with unmet maternal needs causing maternal NON-ADHERENCE - eClinicalMedicine
